Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.

Association between the class II major histocompatibility complex (MHC) and the class II invariant chain-associated peptide (CLIP) occurs naturally as an intermediate step in the MHC class II processing pathway. Here, we report the crystal structure of the murine class II MHC molecule I-A(b) in complex with human CLIP at 2.15A resolution. The structure of I-A(b) accounts, via the peptide-binding groove's unique physicochemistry, for the distinct peptide repertoire bound by this allele. CLIP adopts a similar conformation to peptides bound by other I-A alleles, reinforcing the notion that CLIP is presented as a conventional peptide antigen. When compared to the related HLA-DR3/CLIP complex structure, the CLIP peptide displays a slightly different conformation and distinct interaction pattern with residues in I-A(b). In addition, after examining the published sequences of peptides presented by I-A(b), we discuss the possibility of predicting peptide alignment in the I-A(b) binding groove using a simple scoring matrix.

[1]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[2]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[3]  J. Coligan,et al.  Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains , 1991, The Journal of experimental medicine.

[4]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[5]  A. Rudensky,et al.  A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex‐specific monoclonal antibody , 1996, European journal of immunology.

[6]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[7]  V. Gnau,et al.  Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules , 1995, The Journal of experimental medicine.

[8]  A. Rudensky,et al.  In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses , 2001, European journal of immunology.

[9]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[10]  C. Janeway,et al.  Exogenously Provided Peptides of a Self-antigen Can Be Processed into Forms that Are Recognized by Self–T Cells , 1998, The Journal of experimental medicine.

[11]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[12]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[13]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[14]  R. Mariuzza,et al.  Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. , 2000, Journal of molecular biology.

[15]  C. Janeway,et al.  A novel MHC class II epitope expressed in thymic medulla but not cortex , 1989, Nature.

[16]  R. Germain,et al.  Cell surface expression of hybrid murine/human MHC class II beta alpha dimers. Key influence of residues in the amino-terminal portion of the beta 1 domain. , 1990, Journal of immunology.

[17]  C. Lee,et al.  A general model of invariant chain association with class II major histocompatibility complex proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Zaller,et al.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. , 1997, Immunity.

[19]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[20]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[21]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[22]  P. Cresswell.  Invariant Chain Structure and MHC Class II Function , 1996, Cell.

[23]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[24]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[25]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[26]  B. Chesebro,et al.  Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes , 1988, The Journal of experimental medicine.

[27]  H. Ploegh,et al.  Mapping functional regions in the lumenal domain of the class II- associated invariant chain , 1994, The Journal of experimental medicine.

[28]  C. Janeway,et al.  A Role for Accessibility to Self-Peptide-Self-MHC Complexes in Intrathymic Negative Selection1 , 2001, The Journal of Immunology.

[29]  D. Wiley,et al.  Structure of a covalently stabilized complex of a human αβ T‐cell receptor, influenza HA peptide and MHC class II molecule, HLA‐DR1 , 2000, The EMBO journal.

[30]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[31]  K. Ozato,et al.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. , 1980, Journal of immunology.

[32]  A. Goldrath,et al.  T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates , 1995, The Journal of experimental medicine.

[33]  K. Mason,et al.  Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. , 1995, International immunology.

[34]  A. Smolyar,et al.  The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.

[35]  P. Marrack,et al.  Alternate interactions define the binding of peptides to the MHC molecule IAb , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Janeway,et al.  On the Self-Referential Nature of Naive MHC Class II-Restricted T Cells1 , 2000, The Journal of Immunology.

[37]  R. Schwartz,et al.  Functional analysis of the antigenic structure of a minor T cell determinant from pigeon cytochrome C. Evidence against an alpha-helical conformation. , 1989, Journal of immunology.

[38]  T. Sasazuki,et al.  An endogenously processed self peptide and the corresponding exogenous peptide bound to the same MHC class II molecule could be distinct ligands for TCR with different kinetic stability , 1998, European journal of immunology.

[39]  C. Janeway,et al.  Functional and Phenotypic Evidence for Presentation of Eα52–68 Structurally Related Self-Peptide(s) in I-Eα-Deficient Mice1 , 2000, The Journal of Immunology.

[40]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[41]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  H. Ploegh,et al.  Proteolysis in MHC class II antigen presentation: who's in charge? , 2000, Immunity.

[43]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[44]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[45]  E. Unanue,et al.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.

[46]  P. A. Peterson,et al.  Engineering protein for X‐ray crystallography: The murine major histocompatibility complex class II molecule I‐Ad , 1998, Protein science : a publication of the Protein Society.

[47]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[48]  T. Watts,et al.  Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules. , 1995, International immunology.

[49]  A Sette,et al.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.

[50]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[51]  L. Smith,et al.  A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides , 1994, The Journal of experimental medicine.

[52]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[53]  D. Wiley,et al.  Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[55]  J. Drijfhout,et al.  Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. , 1995, Molecular immunology.

[56]  D. Fremont,et al.  Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.

[57]  A Sette,et al.  T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II. , 1998, Cellular immunology.

[58]  P. A. Peterson,et al.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.

[59]  A. Rudensky,et al.  Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. , 1997, Immunity.

[60]  E. Sercarz,et al.  Processing and Reactivity of T Cell Epitopes Containing Two Cysteine Residues from Hen Egg-White Lysozyme (HEL74–90)1 , 2000, The Journal of Immunology.

[61]  P. A. Peterson,et al.  Altered antigen presentation in mice lacking H2-O. , 1998, Immunity.

[62]  C. Janeway,et al.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells. , 1984, Journal of immunology.

[63]  J. Neefjes,et al.  Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. , 1992, The EMBO journal.

[64]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[65]  A. Rudensky,et al.  Monoclonal antibody detection of a major self peptide. MHC class II complex. , 1992, Journal of immunology.

[66]  M. L. Connolly.  Analytical molecular surface calculation , 1983 .

[67]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[68]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[69]  W. Heath,et al.  Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements , 1998, Immunology and cell biology.

[70]  K. Garcia,et al.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules , 1996, The Journal of experimental medicine.

[71]  A. Liljas,et al.  Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence , 2001, The EMBO journal.

[72]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[73]  Don C. Wiley,et al.  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.

[74]  R. Good,et al.  Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  M. Jackson,et al.  Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[77]  A. Rudensky,et al.  Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[78]  H. Chapman,et al.  Endosomal proteolysis and MHC class II function. , 1998, Current opinion in immunology.

[79]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[80]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.